vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and TENNANT CO (TNC). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $291.6M, roughly 1.7× TENNANT CO). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -1.5%, a 8.3% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -11.3%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -3.2%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
The Tennant Company (TNC:NYQ) is a company with about 4000 employees that provides cleaning products. It is a company that is listed in the New York Stock Exchange.
MD vs TNC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $291.6M |
| Net Profit | $33.7M | $-4.4M |
| Gross Margin | — | 34.6% |
| Operating Margin | 9.9% | -1.4% |
| Net Margin | 6.8% | -1.5% |
| Revenue YoY | -1.7% | -11.3% |
| Net Profit YoY | 10.5% | -166.7% |
| EPS (diluted) | $0.40 | $-0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $291.6M | ||
| Q3 25 | $492.9M | $303.3M | ||
| Q2 25 | $468.8M | $318.6M | ||
| Q1 25 | $458.4M | $290.0M | ||
| Q4 24 | $502.4M | $328.9M | ||
| Q3 24 | $511.2M | $315.8M | ||
| Q2 24 | $504.3M | $331.0M | ||
| Q1 24 | $495.1M | $311.0M |
| Q4 25 | $33.7M | $-4.4M | ||
| Q3 25 | $71.7M | $14.9M | ||
| Q2 25 | $39.3M | $20.2M | ||
| Q1 25 | $20.7M | $13.1M | ||
| Q4 24 | $30.5M | $6.6M | ||
| Q3 24 | $19.4M | $20.8M | ||
| Q2 24 | $-153.0M | $27.9M | ||
| Q1 24 | $4.0M | $28.4M |
| Q4 25 | — | 34.6% | ||
| Q3 25 | — | 42.7% | ||
| Q2 25 | — | 42.1% | ||
| Q1 25 | — | 41.4% | ||
| Q4 24 | — | 41.3% | ||
| Q3 24 | — | 42.4% | ||
| Q2 24 | — | 43.1% | ||
| Q1 24 | — | 44.2% |
| Q4 25 | 9.9% | -1.4% | ||
| Q3 25 | 13.8% | 7.4% | ||
| Q2 25 | 12.8% | 9.6% | ||
| Q1 25 | 7.0% | 6.8% | ||
| Q4 24 | 7.8% | 2.3% | ||
| Q3 24 | 6.6% | 9.7% | ||
| Q2 24 | -31.3% | 11.7% | ||
| Q1 24 | 3.2% | 12.1% |
| Q4 25 | 6.8% | -1.5% | ||
| Q3 25 | 14.5% | 4.9% | ||
| Q2 25 | 8.4% | 6.3% | ||
| Q1 25 | 4.5% | 4.5% | ||
| Q4 24 | 6.1% | 2.0% | ||
| Q3 24 | 3.8% | 6.6% | ||
| Q2 24 | -30.3% | 8.4% | ||
| Q1 24 | 0.8% | 9.1% |
| Q4 25 | $0.40 | $-0.21 | ||
| Q3 25 | $0.84 | $0.80 | ||
| Q2 25 | $0.46 | $1.08 | ||
| Q1 25 | $0.24 | $0.69 | ||
| Q4 24 | $0.37 | $0.35 | ||
| Q3 24 | $0.23 | $1.09 | ||
| Q2 24 | $-1.84 | $1.45 | ||
| Q1 24 | $0.05 | $1.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | — |
| Total DebtLower is stronger | $570.5M | $273.2M |
| Stockholders' EquityBook value | $865.9M | $601.6M |
| Total Assets | $2.2B | $1.3B |
| Debt / EquityLower = less leverage | 0.66× | 0.45× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | — | ||
| Q3 25 | $340.1M | — | ||
| Q2 25 | $224.7M | — | ||
| Q1 25 | $99.0M | — | ||
| Q4 24 | $229.9M | — | ||
| Q3 24 | $103.8M | — | ||
| Q2 24 | $19.4M | — | ||
| Q1 24 | $8.0M | — |
| Q4 25 | $570.5M | $273.2M | ||
| Q3 25 | $577.2M | $238.3M | ||
| Q2 25 | $583.9M | $213.4M | ||
| Q1 25 | $590.5M | $213.3M | ||
| Q4 24 | $597.1M | $198.2M | ||
| Q3 24 | — | $208.6M | ||
| Q2 24 | — | $205.6M | ||
| Q1 24 | — | $207.4M |
| Q4 25 | $865.9M | $601.6M | ||
| Q3 25 | $890.7M | $640.9M | ||
| Q2 25 | $833.8M | $651.9M | ||
| Q1 25 | $789.2M | $624.4M | ||
| Q4 24 | $764.9M | $620.8M | ||
| Q3 24 | $732.5M | $647.2M | ||
| Q2 24 | $706.5M | $624.6M | ||
| Q1 24 | $856.2M | $614.6M |
| Q4 25 | $2.2B | $1.3B | ||
| Q3 25 | $2.2B | $1.3B | ||
| Q2 25 | $2.1B | $1.2B | ||
| Q1 25 | $2.0B | $1.2B | ||
| Q4 24 | $2.2B | $1.2B | ||
| Q3 24 | $2.1B | $1.2B | ||
| Q2 24 | $2.0B | $1.2B | ||
| Q1 24 | $2.2B | $1.2B |
| Q4 25 | 0.66× | 0.45× | ||
| Q3 25 | 0.65× | 0.37× | ||
| Q2 25 | 0.70× | 0.33× | ||
| Q1 25 | 0.75× | 0.34× | ||
| Q4 24 | 0.78× | 0.32× | ||
| Q3 24 | — | 0.32× | ||
| Q2 24 | — | 0.33× | ||
| Q1 24 | — | 0.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $14.2M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 3.3% |
| Capex IntensityCapex / Revenue | — | 1.5% |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $43.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $14.2M | ||
| Q3 25 | $137.3M | $28.7M | ||
| Q2 25 | $137.2M | $22.5M | ||
| Q1 25 | $-117.5M | $-400.0K | ||
| Q4 24 | $133.0M | $37.5M | ||
| Q3 24 | $91.8M | $30.7M | ||
| Q2 24 | $107.0M | $18.6M | ||
| Q1 24 | $-125.2M | $2.9M |
| Q4 25 | — | $9.7M | ||
| Q3 25 | — | $22.3M | ||
| Q2 25 | — | $18.7M | ||
| Q1 25 | — | $-7.4M | ||
| Q4 24 | — | $28.1M | ||
| Q3 24 | — | $26.4M | ||
| Q2 24 | — | $14.4M | ||
| Q1 24 | — | $-100.0K |
| Q4 25 | — | 3.3% | ||
| Q3 25 | — | 7.4% | ||
| Q2 25 | — | 5.9% | ||
| Q1 25 | — | -2.6% | ||
| Q4 24 | — | 8.5% | ||
| Q3 24 | — | 8.4% | ||
| Q2 24 | — | 4.4% | ||
| Q1 24 | — | -0.0% |
| Q4 25 | — | 1.5% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 2.9% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | 1.93× | ||
| Q2 25 | 3.49× | 1.11× | ||
| Q1 25 | -5.66× | -0.03× | ||
| Q4 24 | 4.36× | 5.68× | ||
| Q3 24 | 4.72× | 1.48× | ||
| Q2 24 | — | 0.67× | ||
| Q1 24 | -31.03× | 0.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
TNC
| Equipment Sales | $165.5M | 57% |
| Parts And Consumables | $69.1M | 24% |
| Service And Other | $57.0M | 20% |
